---
title: "Keyuan Pharma (301281.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301281.SZ/norm.md"
symbol: "301281.SZ"
name: "Keyuan Pharma"
parent: "https://longbridge.com/en/quote/301281.SZ.md"
datetime: "2026-03-15T22:50:19.912Z"
locales:
  - [en](https://longbridge.com/en/quote/301281.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301281.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301281.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301281.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301281.SZ/norm.md)


# Keyuan Pharma (301281.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1035 | 0.1810 | 0.2132 | 0.1948 | 0.0332 |
| ROE | -3.26% | 5.67% | 6.74% | 6.11% | 1.08% |
| Revenue | 74.82M | 116.66M | 111.20M | 132.84M | 93.74M |
| Net income | -11.21M | 19.60M | 23.08M | 20.59M | 3.59M |
| Operating income | -5.25M | 14.36M | 18.04M | 2.23M | 4.12M |
| Gross margin | 47.76% | 55.59% | 51.31% | 50.46% | 36.48% |
| Net margin | -14.99% | 16.80% | 20.76% | 15.50% | 3.83% |
| Profit quality | -314.61% | 54.97% | -3266.84% | -2.64% | 69.40% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.61B | 1.60B | 1.58B | 1.55B | 1.46B |
| Leverage | 1.17 | 1.16 | 1.14 | 1.14 | 1.10 |
| BVPS | 12.66 | 12.76 | 12.77 | 12.55 | 12.34 |
| Turnover | 0.2837 | 0.2958 | 0.2784 | 0.3068 | 0.3002 |
| Cash & STI | 326.74M | 368.47M | 397.65M | 432.56M | 453.99M |
| Inv & Rec | 151.08M | 147.48M | 142.45M | 128.94M | 103.94M |
| LT assets | 569.03M | 553.17M | 505.98M | 477.00M | 478.35M |
| Net debt | -229.16M | -272.67M | -330.99M | -386.90M | -453.99M |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 1.67M | 26.12M | -552149.00 | -84.39M | 5.93M |
| Investing CF | -191.30M | 98.46M | -36.79M | -137.91M | 84.21M |
| Financing CF | -505852.00 | 13.03M | 15.45M | 46.56M | 0.0000 |
| Free CF | -53.22M | -24.04M | -70.01M | -81.30M | -66.88M |
| OCF coverage | 8.37% | 32.76% | -1.52% | -102.46% | 11.72% |
| Repaid & issued | 1.78M | 32.61M | 21.01M | 45.62M | - |
| CapEx | -17.66M | -54.59M | -36.39M | -82.29M | -50.63M |

## Distribution Plan

**Dividend Yield**: 0.40

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.2CNY | 2025-05-19 | 2025-05-20 | 2025-05-20 |
| Cash Dividend: 
0.3CNY | 2024-04-29 | 2024-04-30 | 2024-04-30 |
| Cash Dividend: 
0.4CNY. 
Share conversation: 0.4 for 1 | 2023-05-25 | 2023-05-26 | 2023-05-26 |